CAS: 35466-83-2; Allyl Methyl Carbonate

该化合物是一种有机化合物,其特征是其酯功能组和乙烯组,有助于其再活性,典型是一种无色液体,有独特的气味,在乙醇和乙醇等有机溶剂中可溶解,该化合物因其参与聚合反应的能力而闻名,使其在生产各种聚合物和共聚物时有用,其化学结构包括一个附属于碳酸盐混合物的甲基组,这加强了其在化学合成中的再活性.甲基2-丙烯-1-乙基碳酸盐还因其有利的特性而被确认在涂层,粘合物和密封剂的配制中的潜在应用,因此应谨慎处理,因为它可能给接触带来健康风险,包括对皮肤和呼吸系统造成刺激.在实验室或工业环境中与该化合物合作时,应采取适当的安全措施.

结构式图片

相似化合物

1469-70-1 15022-08-9 623-53-0

欧盟法规

REACH注册ECHA物质C&L通报

上下游产品

CAS号107-18-6 烯丙醇 | CAS号79-22-1 氯甲酸甲酯 | CAS号616-38-6 碳酸二甲酯 | CAS号67-56-1 甲醇 | CAS号15022-08-9 碳酸二烯丙酯 | CAS号2937-50-0 氯甲酸烯丙酯 | CAS号124-38-9 二氧化碳 | CAS号6257-10-9 N,N''-DICYCLOHE... | CAS号110-86-1 吡啶 | CAS号1114-69-8 tert-butyl 2-cy... | CAS号3698-28-0 2-烯丙基苯甲醚 | CAS号2049-80-1 烯丙基丙二酸二乙酯 | CAS号3195-24-2 二烯丙基丙二酸二乙酯 | CAS号3333-13-9 1-烯丙基-4-甲基苯 | CAS号3333-20-8 1-烯丙基-3-甲苯 | CAS号3724-55-8 3-丁烯酸甲酯 | CAS号623-43-8 巴豆酸甲酯 | CAS号583-04-0 苯甲酸烯丙酯 | CAS号3739-67-1 双酚A二烯丙基醚

合成工艺路线路线简述

  • 合成目标产物 Allyl Methyl Carbonate 主要起始原料 Dimethyl Carbonate
  • (文献来源)合成步骤主要原料 Dimethyl Carbonate
碳酸二甲酯置于potassium Carbonate体系中,化学反应生成烯丙基甲基碳酸酯
参考文献:Novel Allyl Ethers,Polymers And Polymeric Solid Electrolytes
标题:Novel Allyl Ethers,Polymers And Polymeric Solid Electrolytes

海关参考信息

专利信息


专利号:US-2006287520-A1
优先权日:2005-05-16
标 题 :Synthesis of salinosporamide A and analogues thereof
发明人:DANISHEFSKY SAMUEL J; ENDO ATSUSHI
权利人:DANISHEFSKY SAMUEL J; ENDO ATSUSHI
摘要:A novel synthesis of salinosporamide A is provided. Salinospoamide A as well as structurally related natural products, omuralide and lactacystin, have been shown to be proteasome inhibitors. Therefore, these compounds as well as analogues of these natural products may be useful in the treatment of proliferative diseases such as cancer, autoimmune diseases, diabetic retinopathy, etc. The invention provides for the synthesis of salinosporamide A as well as analogs thereof using a convenient point for derivatization of the bicyclic core. Pharmaceutical compositions and method of using the inventive compounds are also provided.

专利号:US-7910623-B2
优先权日:2005-07-22
标 题 :Synthesis of scabronines and analogues thereof
发明人:DANISHEFSKY SAMUEL J; WATERS STEPHEN P
权利人:SLOAN KETTERING INST CANCER
摘要:A novel synthesis of scabronines, which are related to a broader class of angularly fused tricyclic diterpenoids known as cyathanes, is provided. Scabronine G, its methyl ester derivative, and other analogs have been shown to have neurotrophic activity. Therefore, these compounds are particularly useful in treating neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, Huntington's diseases, etc. The invention provides for the synthesis of scabronines as well as analogs thereof. Pharmaceutical compositions and method of using the inventive compounds are also provided.

专利号:WO-2012047907-A9
优先权日:2010-10-04
标题 :Synthesis of c5-substituted tetracyclines, uses thereof, and intermediates thereto
发明人:MYERS ANDREW G; WRIGHT PETER M; HECKER EVAN
权利人:HARVARD COLLEGE; MYERS ANDREW G; WRIGHT PETER M; HECKER EVAN
摘要:The tetracycline class of antibiotics has played a major role in the treatment of infectious diseases for the past 50 years. However, the increased use of the tetracyclines in human and veterinary medicine has led to resistance among many organisms previously susceptible to tetracycline antibiotics. The recent development of a modular synthesis of tetracycline analogs through a chiral enone intermediate has allowed for the efficient synthesis of novel tetracycline analogs never prepared before. The present invention provides more efficient routes for preparing the enone intermediate and allows for a wide variety of substituents at position 5 of the tetracycline ring system.

专利号:US-9688644-B2
优先权日:2009-04-30
标 题 :Synthesis of Tetracyclines and intermediates thereto
发明人:MYERS ANDREW G; KUMMER DAVID A; LI DERUN; HECKER EVAN; DION AMELIE; WRIGHT PETER M
权利人:HARVARD COLLEGE
摘要:The tetracycline class of antibiotics has played a major role in the treatment of infectious diseases for the past 50 years. However, the increased use of the tetracyclines in human and veterinary medicine has led to resistance among many organisms previously susceptible to tetracycline antibiotics. The recent development of a modular synthesis of tetracycline analogs through a chiral enone intermediate has allowed for the efficient synthesis of novel tetracycline analogs never prepared before. The present invention provides more efficient routes for preparing the enone intermediate and allows for substituents at positions 4a, 5, 5a, and 12a of the tetracycline ring system.

专利号:US-9884830-B2
优先权日:2004-05-21
标题 :Synthesis of tetracyclines and analogues thereof
发明人:MYERS ANDREW G; CHAREST MARK G; LERNER CHRISTIAN D; BRUBAKER JASON D; SIEGEL DIONICIO R
权利人:HARVARD COLLEGE
摘要:The tetracycline class of antibiotics has played a major role in the treatment of infectious diseases for the past 50 years. However, the increased use of the tetracyclines in human and veterinary medicine has led to resistance among many organisms previously susceptible to tetracycline antibiotics. The modular synthesis of tetracyclines and tetracycline analogs described provides an efficient and enantioselective route to a variety of tetracycline analogs and polycyclines previously inaccessible via earlier tetracycline syntheses and semi-synthetic methods. These analogs may be used as anti-microbial agents or anti-proliferative agents in the treatment of diseases of humans or other animals.

专利号:US-8907104-B2
优先权日:2006-10-11
标 题 :Synthesis of enone intermediate
发明人:MYERS ANDREW G; BRUBAKER JASON D
权利人:HARVARD COLLEGE
摘要:The tetracycline class of antibiotics has played a major role in the treatment of infectious diseases for the past 50 years. However, the increased use of the tetracyclines in human and veterinary medicine has led to resistance among many organisms previously susceptible to tetracycline antibiotics. The recent development of a modular synthesis of tetracycline analogs through a chiral enone intermediate has allowed for the efficient synthesis of novel tetracycline analogs never prepared before. The present invention provides a more efficient route for preparing the enone intermediate.
上海富蔗化工有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.fuzhechem.com
企业联系电话:021-66402541,66402542,13901914741👤
📞上海富蔗化工有限公司 ⚠️参考联系方式
联系人:文君
电话:021-66402541,66402542,13901914741
手机:13901914741
传真:021-66402542
邮箱:2308653804@qq.com
通信地址: 上海市汶水路301号
邮编: 200442
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:上海市汶水路301号
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
常州市力仁医药科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.lirenchem.com
企业联系电话:0519-85859058,13915836899👤
📞常州市力仁医药科技有限公司 ⚠️参考联系方式
联系人:黄经理
电话:0519-85859058,13915836899
手机:13915836899
传真:0519-85852385,QQ:3003793626
邮箱:liren_medicine@163.com
通信地址: 江苏省常州市天宁区东仓桥弄1号
邮编: 213000
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:江苏省常州市天宁区东仓桥弄1号
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
海门瑞一医药科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.ruiyitech.cn
企业联系电话:021-54718086👤
📞海门瑞一医药科技有限公司 ⚠️参考联系方式
联系人:余小姐
电话:021-54718086

传真:021-54711707
邮箱:sales5@ruiyitech.com
通信地址: 江苏海门大庆路19号
邮编: 226100
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:江苏海门大庆路19号
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


摘要:Spivey, A. C.; Tseng, C.-C., Science of Synthesis Knowledge Updates, (2010) 1, 5.
摘要:Spivey, A. C.; Tseng, C.-C., Science of Synthesis Knowledge Updates, (2010) 1, 71.
摘要:Delvos, L. B.; Oestreich, M., Science of Synthesis Knowledge Updates, (2017) 1, 137.
摘要:Joule, J. A., Science of Synthesis Knowledge Updates, (2010) 2, 89.
摘要:Harris, P. A., Science of Synthesis Knowledge Updates, (2021) 3, 26.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知